D Lodge

1.8k total citations
26 papers, 1.5k citations indexed

About

D Lodge is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Psychiatry and Mental health. According to data from OpenAlex, D Lodge has authored 26 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 19 papers in Cellular and Molecular Neuroscience and 3 papers in Psychiatry and Mental health. Recurrent topics in D Lodge's work include Neuroscience and Neuropharmacology Research (18 papers), Ion channel regulation and function (8 papers) and Pharmacological Receptor Mechanisms and Effects (7 papers). D Lodge is often cited by papers focused on Neuroscience and Neuropharmacology Research (18 papers), Ion channel regulation and function (8 papers) and Pharmacological Receptor Mechanisms and Effects (7 papers). D Lodge collaborates with scholars based in United Kingdom, United States and Canada. D Lodge's co-authors include Kenneth M. Johnson, David Martin, Elizabeth J. Fletcher, John D. Millar, Chris G. Parsons, N.R. Burton, Nabil A. Anis, Sophie Zeman, Julia Aram and Paul L. Ornstein and has published in prestigious journals such as The Journal of Physiology, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

D Lodge

26 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D Lodge United Kingdom 14 1.1k 811 240 175 154 26 1.5k
A.R. Knight United States 7 1.4k 1.3× 1.0k 1.3× 174 0.7× 231 1.3× 98 0.6× 16 1.8k
István Tarnawa Hungary 17 851 0.7× 603 0.7× 184 0.8× 127 0.7× 104 0.7× 39 1.1k
Janine M. Barnes United Kingdom 19 1.2k 1.0× 896 1.1× 155 0.6× 312 1.8× 232 1.5× 32 1.7k
M.B. Emerit France 25 1.4k 1.2× 1.2k 1.5× 152 0.6× 155 0.9× 124 0.8× 49 2.1k
Nigel R. Newberry United Kingdom 22 1.6k 1.4× 1.1k 1.3× 182 0.8× 450 2.6× 91 0.6× 51 1.9k
Christian Thomsen Denmark 21 1.3k 1.1× 1.0k 1.3× 243 1.0× 168 1.0× 79 0.5× 38 1.9k
C.C. Mao United States 14 971 0.8× 576 0.7× 229 1.0× 204 1.2× 92 0.6× 19 1.5k
Dominique Fage France 21 1.0k 0.9× 780 1.0× 228 0.9× 181 1.0× 209 1.4× 38 1.7k
Lawrence W. Fitzgerald United States 23 944 0.8× 649 0.8× 180 0.8× 249 1.4× 200 1.3× 42 2.0k
Shigehiko Narumi Japan 17 742 0.6× 550 0.7× 143 0.6× 195 1.1× 137 0.9× 47 1.2k

Countries citing papers authored by D Lodge

Since Specialization
Citations

This map shows the geographic impact of D Lodge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D Lodge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D Lodge more than expected).

Fields of papers citing papers by D Lodge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D Lodge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D Lodge. The network helps show where D Lodge may publish in the future.

Co-authorship network of co-authors of D Lodge

This figure shows the co-authorship network connecting the top 25 collaborators of D Lodge. A scholar is included among the top collaborators of D Lodge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D Lodge. D Lodge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jones, Nicole M., C A Hicks, Mark Ward, et al.. (2000). Neuroprotective Effects of LY379268, a Selective mGlu2/3 Receptor Agonist: Investigations into Possible Mechanism of Action In Vivo. Journal of Pharmacology and Experimental Therapeutics. 294(3). 800–809. 87 indexed citations
2.
Price-Jones, Molly, et al.. (1999). Measurement of calcium flux through ionotropic glutamate receptors using Cytostar-T scintillating microplates. Journal of Neuroscience Methods. 90(1). 33–36. 10 indexed citations
3.
Houghton, Andrea K., E. S. Louise Faber, Boris A. Chizh, et al.. (1998). Actions of kainate and AMPA selective glutamate receptor ligands on nociceptive processing in the spinal cord. Neuropharmacology. 37(10-11). 1287–1297. 48 indexed citations
4.
Soriano, Marc A., et al.. (1998). Effects of the selective metabotropic glutamate agonist LY354740 in a rat model of permanent ischaemia. Neuroscience Letters. 254(2). 121–123. 34 indexed citations
5.
McQuaid, Loretta A., Edward C. Smith, Charles H. Mitch, et al.. (1992). Synthesis and excitatory amino acid pharmacology of a series of heterocyclic-fused quinoxalinones and quinazolinones. Journal of Medicinal Chemistry. 35(18). 3319–3324. 50 indexed citations
6.
Zeman, Sophie & D Lodge. (1992). Pharmacological characterization of non‐NMDA subtypes of glutamate receptor in the neonatal rat hemisected spinal cord in vitro. British Journal of Pharmacology. 106(2). 367–372. 34 indexed citations
7.
Church, John & D Lodge. (1990). Anticonvulsant actions of phencyclidine receptor ligands: Correlation with N-Methylaspartate Antagonism in vivo. General Pharmacology The Vascular System. 21(2). 165–170. 7 indexed citations
8.
Schoepp, Darryle D., Paul L. Ornstein, J. David Leander, et al.. (1990). Pharmacological characterization of LY233053: a structurally novel tetrazole-substituted competitive N-methyl-D-aspartic acid antagonist with a short duration of action.. Journal of Pharmacology and Experimental Therapeutics. 255(3). 1301–1308. 17 indexed citations
9.
Ornstein, Paul L., et al.. (1990). LY233053: a structurally novel, potent and selective competitive N-methyl-D-aspartate receptor antagonist.. PubMed. 361. 429–33. 1 indexed citations
10.
Church, John & D Lodge. (1990). Cyclazocine and pentazocine as N-methylaspartate antagonists on cat and rat spinal neurons in vivo.. Journal of Pharmacology and Experimental Therapeutics. 253(2). 636–645. 13 indexed citations
11.
Lodge, D & Kenneth M. Johnson. (1990). Noncompetitive excitatory amino acid receptor antagonists. Trends in Pharmacological Sciences. 11(2). 81–86. 309 indexed citations
12.
13.
Fletcher, Elizabeth J., David Martin, Julia Aram, D Lodge, & T. Honoré. (1988). Quinoxalinediones selectively block quisqualate and kainate receptors and synaptic events in rat neocortex and hippocampus and frog spinal cordin vitro. British Journal of Pharmacology. 95(2). 585–597. 93 indexed citations
14.
Davies, S.N., et al.. (1986). 2-methyl-3,3-diphenyl-3-propanolamine (2-MDP) selectively antagonises N-methyl-aspartate (NMA). Pharmacology Biochemistry and Behavior. 24(1). 23–25. 7 indexed citations
15.
Martin, David & D Lodge. (1985). Ketamine acts as a non-competitive N-methyl-d-aspartate antagonist on frog spinal cord in vitro. Neuropharmacology. 24(10). 999–1003. 158 indexed citations
16.
Lodge, D, Nabil A. Anis, & N.R. Burton. (1982). Effects of optical isomers of ketamine on excitation of cat and rat spinal neurones by amino acids and acetylcholine. Neuroscience Letters. 29(3). 281–286. 104 indexed citations
17.
Lodge, D, et al.. (1979). Mutagenic activity of propylene oxide in bacterial and mammalian systems. Mutation Research/Genetic Toxicology. 67(2). 101–112. 54 indexed citations
18.
Craig, Charles R., D.R. Curtis, & D Lodge. (1977). Dual effects of hemicholinium‐3 at central cholinergic synapses.. The Journal of Physiology. 264(2). 367–377. 6 indexed citations
19.
Lodge, D & P.M. Headley. (1974). ANAESTHETIC AGENTS AND CENTRAL SYNAPSE. 5(1). 18–24. 1 indexed citations
20.
Duggan, A.W., et al.. (1973). Effect of nuciferine on the chemical excitation of Renshaw cells in the rat.. PubMed. 204(1). 147–9. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A.R. Knight Breakdown of academic impact, for papers by István Tarnawa Breakdown of academic impact, for papers by Janine M. Barnes Breakdown of academic impact, for papers by M.B. Emerit Breakdown of academic impact, for papers by Nigel R. Newberry Breakdown of academic impact, for papers by Christian Thomsen Breakdown of academic impact, for papers by C.C. Mao Breakdown of academic impact, for papers by Dominique Fage Breakdown of academic impact, for papers by Lawrence W. Fitzgerald Breakdown of academic impact, for papers by Shigehiko Narumi
Rankless by CCL
2026